Active, not recruitingPhase 3NCT03978000
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study
Studying Necrotizing enterocolitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Infant Bacterial Therapeutics
- Principal Investigator
- Josef Neu, MDUniversity of Florida College of Medicine, Gainsville, FL
- Intervention
- IBP-9414(drug)
- Enrollment
- 2158 target
- Eligibility
- All sexes
- Timeline
- 2019 – 2024
Study locations (30)
- Banner University Medical Center / University of Arizona, Tucson, Arizona, United States
- Arkansas Children'S Hospital, Little Rock, Arkansas, United States
- University of Arkansas For Medical Services, Little Rock, Arkansas, United States
- Loma Linda University Children Hospital, Loma Linda, California, United States
- Good Samaritan Hospital, Los Angeles, California, United States
- LAC & USC Medical Center, Los Angeles, California, United States
- University of Califorina, Los Angeles (UCLA), Los Angeles, California, United States
- Valley Childrens Hospital, Madera, California, United States
- Sharp Memorial Hospital, San Diego, California, United States
- St. Francis Medical Center, Colorado Springs, Colorado, United States
- Connecticut Children'S Medical Center - Uconn - School of Medicine, Hartford, Connecticut, United States
- University of Florida Health, Gainesville, Florida, United States
- Wolfson Children'S Hospital, Jacksonville, Florida, United States
- Uf Health Jacksonville, Jacksonville, Florida, United States
- University of Miami/Holtz Children'S Hospital, Miami, Florida, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03978000 on ClinicalTrials.govOther trials for Necrotizing enterocolitis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07490834Long-term Nutritional Impact of Necrotizing Enterocolitis in Premature Newborns.Central Hospital, Nancy, France
- RECRUITINGNCT07192393Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).Imperial College London
- RECRUITINGNANCT06727877Predictive Diagnosis of Ulcero-Necrotizing EnteroColitis in Premature Babies Using an Artificial Intelligence Approach Based on Early Analysis of the Fecal MicrobiotaUniversity Hospital, Clermont-Ferrand
- RECRUITINGNCT06681129Study of Normal Intestinal Development and Disease in Premature and Term NeonatesBoston Children's Hospital
- ACTIVE NOT RECRUITINGNCT06850896Antibiotic Exposure on Gut Microbiota and Motility Establishment in NewbornsThe First Hospital of Jilin University
- RECRUITINGNCT07152106Amniotic Fluid & the Preterm GutMaxima Medical Center
- RECRUITINGNANCT06672913Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter StudyBaskent University Ankara Hospital
- ACTIVE NOT RECRUITINGNANCT06908239Milk Temperature Control and Necrotizing Enterocolitis Risk in Extremely Preterm InfantsDaping Hospital and the Research Institute of Surgery of the Third Military Medical University